Evidence map›Paper›PMID 42146795›Full record

ArticleChemical science2026

MAPLE: a machine-learning force-field-native platform for automated reaction modeling and enzyme design.

Xujian Wang, Zeyu Sun, Yilu Zhang, Carlo Asam, Ruzhan Zhu, Wan-Lu Li, Junmei Wang

Abstract read
In one paragraph

Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xujian WangDepartment of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy, University of Pittsburgh Pittsburgh Pennsylvania 15261 USA junmei.wang@pitt.edu.ORCID https://orcid.org/0009-0004-0146-9991
Zeyu SunDepartment of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy, University of Pittsburgh Pittsburgh Pennsylvania 15261 USA junmei.wang@pitt.edu.
Yilu ZhangDepartment of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy, University of Pittsburgh Pittsburgh Pennsylvania 15261 USA junmei.wang@pitt.edu.
Carlo AsamAiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San Diego CA 92093 USA wal019@ucsd.edu.
Ruzhan ZhuSchool of Engineering, Computer and Mathematical Sciences, Auckland University of Technology Auckland 1010 New Zealand.
Wan-Lu LiAiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San Diego CA 92093 USA wal019@ucsd.edu.ORCID https://orcid.org/0000-0003-0098-0670
Junmei WangDepartment of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy, University of Pittsburgh Pittsburgh Pennsylvania 15261 USA junmei.wang@pitt.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Machine-learning force fields (MLFFs) are reshaping computational chemistry and biology by delivering near-quantum mechanical accuracy at a computational cost comparable to conventional force fields, enabling applications in biomolecular simulation, catalysis, and materials science. However, despite these advances, a unified and automated computational platform enabling the broader application of MLFFs is still lacking. Here, we present MAPLE (MAchine learning Potential for Landscape Exploration), a computational toolkit specially developed for MLFF-based molecular modeling, featuring a tailored software framework and parallelized algorithms for large-scale and versatile molecular modeling tasks. We demonstrated the robustness and usability of MAPLE through systematic benchmarking of state-of-the-art reactive MLFFs and applications to multiple biocatalytic scenarios, highlighting its capability for fast yet accurate simulation of catalytic reactions. By integrating accurate and efficient MLFFs with parallelized algorithms in a highly optimized and flexible software framework, MAPLE serves as a next-generation, physically informed, machine-learning-driven molecular modeling platform with broad applicability to rational catalyst design and drug discovery.

Identifiers

PMID42146795
PMCPMC13177203

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.